NDAQ
Outperforming without a clear catalyst yet
- NDAQ +1.84% on the last session vs SPY +0.10%: +1.7 pts of stock-specific move.
- Earnings Oct 22 before the open: EPS $1.02 expected (15 analysts); it moved ±1.7% on average after its last 8 reports.
- Aftermath, big gain (+1.8% today so far, past its big-gain line of +1.8%): After its 67 big gains in the past 5 years, NDAQ was higher a week later 37 times out of 67; half the outcomes fell between -2.0% and +2.3%. History, not a forecast.
- 2 analyst actions in the past 10 days (0 positive, 2 negative); latest: Morgan Stanley maintained Overweight, lowered target $120 → $118.
- Market backdrop (Today): Core PPI m/m 1.3% vs 0.3% expected (hotter); Core Retail Sales m/m 0.9% vs 0.6% expected (stronger); S&P futures -0.08%, 10-year yield -3bp in the 30 minutes after.
Insiders
Officers, directors and 10% owners file SEC Form 4 within two business days. Unplanned: the insider chose to trade now, the trades worth attention; their dollars make the net above. 10b5-1 plan: scheduled in advance, kept for the record. Tax: shares withheld on vesting stock, not a market trade. Awards, option exercises and gifts are left out. Source: SEC EDGAR, collected daily for the stocks discussed on Reddit.
Congress
| Trade date | Member | Chamber | Side | Amount | Disclosed |
|---|---|---|---|---|---|
| Aug 25, 2026 | April McClain Delaney | House | Sell | $100K–$250K | Sep 9 |
| Apr 24, 2026 | April McClain Delaney | House | Buy | $1K–$15K | May 6 |
| Mar 31, 2026 | April McClain Delaney | House | Buy | $1K–$15K | Apr 6 |
| Mar 27, 2026 | Alan Armstrong | Senate | Sell | $50K–$100K | Jul 21 |
| Mar 18, 2026 | April McClain Delaney | House | Buy | $1K–$15K | Apr 6 |
| Mar 10, 2026 | April McClain Delaney | House | Buy | $1K–$15K | Apr 6 |
| Mar 9, 2026 | April McClain Delaney | House | Buy | $1K–$15K | Apr 6 |
| Mar 4, 2026 | April McClain Delaney | House | Buy | $1K–$15K | Apr 6 |
| Mar 3, 2026 | April McClain Delaney | House | Buy | $1K–$15K | Apr 6 |
| Feb 27, 2026 | April McClain Delaney | House | Buy | $1K–$15K | Mar 10 |
| Oct 22, 2025 | April McClain Delaney | House | Buy | $15K–$50K | Nov 4 |
| Oct 9, 2025 | April McClain Delaney | House | Buy | $1K–$15K | Nov 4 |
| Sep 19, 2025 | April McClain Delaney | House | Buy | $15K–$50K | Oct 6 |
Members of Congress report trades within 45 days of the trade date, so these are never real-time. Amounts are disclosed as ranges; the net uses each range's midpoint (≈). Source: House and Senate periodic transaction reports via CongressInvests, refreshed daily.
Funds
| Investor | Shares | Value | Of its portfolio | Vs quarter before | As of |
|---|---|---|---|---|---|
| Bridgewater (Ray Dalio's firm) | 80,751 | $6.4M | 0.03% | new | Q2 2026 |
Well-known investors we follow (Buffett, Ackman, Icahn, Druckenmiller, Tepper, Soros and others). 13F: managers report their US stock holdings up to 45 days after each quarter; the change from the quarter before is dated by the filing, the trades happened some time in the quarter, and the value is at the quarter-end price (≈). New and closed positions, and adds or cuts of 20% or more, of positions at least 0.2% of the portfolio. ARK: Cathie Wood's ETFs publish their holdings every morning; the change beyond the fund's own inflows and outflows, dated by the session it traded. 5%+ stake: Schedule 13D (with intent to influence) or 13G (passive), filed within days. Source: SEC EDGAR, ark-funds.com, refreshed daily. Who holds it: each investor's latest 13F portfolio (positions at the quarter's end; one sold since would not show until the next filing), and ARK's ETFs as of their latest daily file. The funds we follow and their portfolios · All recent insider, congressional and fund moves